Statistics for MaaT Pharma SA (id:10894 MAAT)
Valuation metrics
Market cap
114.46M
Enterprise value
100.71M
Trailing P/E (ttm)
Forward P/E
-3.20
PEG ratio
Price/Sales (ttm)
44.52
Price/Book (mrq)
4.48
Enterprise Value/Revenue
39.17
Enterprise Value/EBITDA
-4.21
Overview
Shares outstanding
13.89M
Float
3.58M
Shares short
% Held by insiders
0.28%
% Held by institutions
0.49%
Average volume (10 days)
3.60K
Average volume (90 days)
Price summary
52-Week low
6.30
52-Week high
9.90
52-Week change
12.21%
Beta
0.19
50-Day moving average
7.39
200-Day moving average
7.87
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
December 31th, 2023
Profitability
Profit margin
74.28%
Operating margin
-741.20%
Operational effectiveness
Return on assets
-29.99%
Return on equity
-84.85%
Income statement
Revenue (ttm)
0.22
Revenue per share (ttm)
0.22
Quarterly revenue growth (yoy)
Gross profit (ttm)
1.66M
EBITDA
-23,943,000.00
Net income to common (ttm)
-24,138,000.00
Diluted EPS (ttm)
-1.70
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
31.15M
Total cash per share (mrq)
2.24
Total debt (mrq)
17.17M
Total Debt/Equity (mrq)
67.04
Current ratio (mrq)
276.10%
Book value per share (mrq)
1.84
Cash flow
Cash flow statement
-18,202,000.00
Levered free cash flow (LFCF)
-8,767,500.00